Business
Kane Biotech to Present at Advanced Wound Care Summit USA
WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kan...
About this update from Kane Biotech Inc.
[{"type":"text","content":"Kane Biotech to Present at Advanced Wound Care Summit USA\n\n\n\n WINNIPEG, Manitoba, July 14, 2025 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE) (“Kane Biotech” or “Kane”) announces today that Kane Biotech’s Interim Chief Executive Officer, Dr. Robert Huizinga, will be presenting at the 4\n \n th\n \n Advanced Wound Care Summit USA taking place from July 15-17, 2025 in Boston, MA.\n \n\n The Advanced Wound Care Summit USA is an industry gathering dedicated to the business of wound care where innovators, payers, regulators, and multinational leaders come together to turn breakthrough science into profitable, accessible therapies.\n \n\n Dr. Huizinga’s presentation will be available on Kane’s website as of July 16, 2025.\n \n\n\n About Kane Biotech\n \n\n\n Kane Biotech is developing novel wound care treatments that disrupt biofilms and transform healing outcomes. Biofilms are one of the main contributors to antibiotic resistance in wounds which results in serious clinical outcomes and significant cost. revyve™ addresses both biofilms and wound bacteria.\n \n\n\n For more information:\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n Dr. Robert Huizinga\n \n\n\n\n Ray Dupuis\n \n\n\n\n\n\n\n Interim CEO\n \n\n Chief Financial Officer\n \n\n\n\n\n\n Kane Biotech Inc\n \n\n Kane Biotech Inc\n \n\n\n\n\n\n\n [email protected]\n \n\n\n\n [email protected]\n \n\n\n\n\n\n\n (780) 970-1100\n \n\n (204) 298-2200\n \n\n\n\n\n\n\n\n Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.\n \n\n\n\n Caution Regarding Forward-Looking Information\n \n\n\n This press release contains certain statements regarding Kane Biotech Inc. that constitute forward-looking information under applicable securities law. These statements reflect management’s current beliefs and are based on information currently available to management. Certain material factors or assumptions are applied in making forward-looking statements, and actual results may differ materially from those expressed or implied in such statements. These risks and uncertainties include, but are not limited to, risks relating to the Company’s: (a) financial co...